Takeda completes acquisition of cell therapy company TiGenix

The Japan-based company has acquired all outstanding ordinary shares and warrants of the biopharma company, with the original bid being announced back in January
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news